-
公开(公告)号：US11793806B2
公开(公告)日：2023-10-24
申请号：US17221423
申请日：2021-04-02
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Shin-San Michael Su , Lenny Dang
IPC: A61K31/535 , A61K31/496 , A61K31/4965 , A61K31/497 , A61P7/06 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/20 , C07D271/12 , C07D295/192 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12 , C07C307/10 , C07D241/04 , A61K31/415 , A61K31/4406 , A61K31/47 , C07C13/04 , C07D307/14
CPC classification number: A61K31/496 , A61K31/497 , A61K31/4965 , A61K31/535 , A61P7/06 , C07C307/10 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/04 , C07D241/20 , C07D271/12 , C07D295/192 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12 , A61K31/415 , A61K31/4406 , A61K31/47 , C07C13/04 , C07D307/14
Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
-
公开(公告)号：US20210220351A1
公开(公告)日：2021-07-22
申请号：US17221423
申请日：2021-04-02
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Shin-San Michael Su , Lenny Dang
IPC: A61K31/496 , A61K31/535 , A61K31/4965 , A61K31/497 , A61P7/06 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/20 , C07D271/12 , C07D295/192 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12 , C07C307/10 , C07D241/04
Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
-
公开(公告)号：US20170290825A1
公开(公告)日：2017-10-12
申请号：US15583412
申请日：2017-05-01
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Shin-San Michael Su
IPC: A61K31/496 , C07C307/10 , C07D241/04
CPC classification number: A61K31/496 , A61K31/415 , A61K31/4406 , A61K31/47 , A61K31/4965 , A61K31/497 , A61K31/535 , C07C13/04 , C07C307/10 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/04 , C07D241/20 , C07D271/12 , C07D295/192 , C07D307/14 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12
Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
-
公开(公告)号：US20200289502A1
公开(公告)日：2020-09-17
申请号：US16821101
申请日：2020-03-17
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Shin-San Michael Su , Lenny Dang
IPC: A61K31/496 , A61K31/535 , A61K31/4965 , A61K31/497 , A61P7/06 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/20 , C07D271/12 , C07D295/192 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12 , C07C307/10 , C07D241/04
Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
-
公开(公告)号：US20200281501A1
公开(公告)日：2020-09-10
申请号：US16790860
申请日：2020-02-14
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Lenny Dang , Valeria Fantin , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Francesco G. Salituro , Jeffrey O. Saunders , Shin-San Michael Su , Katharine Yen
IPC: A61B5/055 , A61K31/41 , A61K31/426 , A61K45/06 , C12N15/113 , G01N33/574 , G16H40/63 , C12Q1/32 , C12Q1/6886
Abstract: Methods of treating and evaluating subjects having neoactive mutants are described herein.
-
Patent Agency Ranking
公开(公告)号：US09682080B2
公开(公告)日：2017-06-20
申请号：US14886750
申请日：2015-10-19
Applicant: AGIOS PHARMACEUTICALS, INC
Inventor： Shin-San Michael Su
IPC: A61K31/535 , C07D413/00 , A61K31/496 , A61K31/4965 , A61K31/497 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/20 , C07D271/12 , C07D295/192 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12
CPC classification number: A61K31/496 , A61K31/415 , A61K31/4406 , A61K31/47 , A61K31/4965 , A61K31/497 , A61K31/535 , C07C13/04 , C07C307/10 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/04 , C07D241/20 , C07D271/12 , C07D295/192 , C07D307/14 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12
Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
-
公开(公告)号：US20170044620A1
公开(公告)日：2017-02-16
申请号：US15238161
申请日：2016-08-16
Applicant: AGIOS PHARMACEUTICALS, INC.
Inventor： Leonard Luan C. Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC: C12Q1/68 , A61K31/194
CPC classification number: C12Q1/6886 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/194 , A61K31/225 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/063 , A61K38/44 , C12Q1/32 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/136 , C12Q2600/156
Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
Abstract translation: 治疗和评估具有IDH（例如，IDH1或IDH2）的新生突变体的受试者的方法。
-
公开(公告)号：US10711314B2
公开(公告)日：2020-07-14
申请号：US15963784
申请日：2018-04-26
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Leonard Luan C. Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC: C12Q1/32 , C12Q1/6886 , A61K31/225 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/06 , A61K38/44 , A61K31/194
Abstract: Methods of diagnosing subjects having a cell proliferation-related disorder or suspected of having a cell proliferation-related disorder associated with mutant IDH enzymes with 2HG neoactivity.
-
公开(公告)号：US09982309B2
公开(公告)日：2018-05-29
申请号：US15238161
申请日：2016-08-16
Applicant: AGIOS PHARMACEUTICALS, INC.
Inventor： Leonard Luan C. Dang , Stefan Gross , Hyun Gyung Jang , Shengfang Jin , Shin-San Michael Su , Craig Thompson
IPC: A61K31/225 , C12Q1/68 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/06 , A61K38/44 , C12Q1/32 , A61K31/194
CPC classification number: C12Q1/6886 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/194 , A61K31/225 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/522 , A61K31/7004 , A61K31/713 , A61K38/063 , A61K38/44 , C12Q1/32 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/136 , C12Q2600/156
Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
-
公开(公告)号：US09980961B2
公开(公告)日：2018-05-29
申请号：US15583412
申请日：2017-05-01
Applicant: Agios Pharmaceuticals, Inc.
Inventor： Shin-San Michael Su , Lenny Dang
IPC: A61K31/535 , C07D413/00 , A61K31/496 , C07D241/04 , C07C307/10 , A61K31/4406 , C07C13/04 , A61K31/47 , C07D307/14 , A61K31/415
CPC classification number: A61K31/496 , A61K31/415 , A61K31/4406 , A61K31/47 , A61K31/4965 , A61K31/497 , A61K31/535 , C07C13/04 , C07C307/10 , C07D205/04 , C07D213/81 , C07D215/14 , C07D235/06 , C07D241/04 , C07D241/20 , C07D271/12 , C07D295/192 , C07D307/14 , C07D333/24 , C07D401/12 , C07D405/12 , C07D417/12
Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.025 seconds)
